Priority Health, a Michigan-based insurer, announced on Wednesday that it has introduced two new cancer support solutions for employers through partnerships with Color Health and Grail.
The insurer serves more than 1.4 million members across Michigan, Indiana, Ohio, and Wisconsin. The newly introduced cancer support solutions will become available to large self‑funded employers beginning January 1. Through these solutions, Priority Health’s employer clients can provide cancer navigation, support, and screening via Color Health’s virtual cancer clinic, as well as early cancer detection using Grail’s blood test. Employers have the option to adopt either solution or both.
Color Health operates a 50‑state medical network. The company delivers at‑home cancer screening and testing, round‑the‑clock access to clinical care, and a dedicated care team focused on cancer. It offers support throughout diagnosis, treatment, and survivorship, and its clinic is certified by the American Society of Clinical Oncology.
Meanwhile, Grail’s Galleri blood test screens for more than 50 cancer types in a single test, encompassing breast, colon, melanoma, and stomach cancers, among others.
Priority Health selected these partners to enable earlier cancer detection and deliver more personalized support to its members, said Chase Osbourne, senior vice president of employer solutions and innovation at Priority Health.
“Color Health provides a comprehensive model that combines screening with expert navigation, helping members assess their risk, complete recommended screenings, and progress through subsequent steps with assistance,” Osbourne explained to MedCity News. “GRAIL delivers innovative multi‑cancer early detection technology capable of identifying cancer signals across numerous cancer types, including those lacking standard screening protocols. Our selection criteria emphasized clinical credibility, member experience, employer value, scalability, and the capacity to complement Priority Health’s broader whole‑person care strategy.”
These partnerships emerge against a backdrop in which the National Institutes of Health projects a 34 % increase in cancer spending by 2030. Moreover, approximately 88 % of employers identify cancer as a primary driver of healthcare costs, according to a Business Group on Health survey.
By collaborating with Color Health and Grail, Priority Health seeks to enable employers to adopt a more proactive stance toward cancer, Osbourne noted.
“By expanding access to earlier screening and personalized navigation, we aim to facilitate faster diagnosis, enhance treatment adherence, and improve outcomes for members,” he said. “We also intend to provide employers with solutions that can mitigate the effects of late‑stage cancer diagnoses on healthcare expenditures, employee absenteeism, and workforce well‑being. Ultimately, this initiative is designed to support individuals earlier, more thoughtfully, and with reduced confusion during what can be a stressful experience.”
Other organizations offering cancer support solutions include Thyme Care, OncoveryCare, and Maia Oncology.
Photo: mucahiddin, Getty Images
Also Read
- STAT+: Fatal gene-editing trial in China raises ethics and oversight questions
- Healthcare Investors Pivot to Revenue-Driven AI Strategies as Traditional Cost-Cutting Yields Diminishing Returns
- Male Nurses Now Account for One‑Eighth of the U.S. Nursing Workforce, Growth Focused on Shortage Regions
- AHRQ Terminates Funding for Dozens of Health Research Projects